Cargando…
Xiaoyukang Jiaonang Promotes the Degradation of Hypoxia-Inducible Factor 1α and Antiangiogenesis and Anti-Inflammation in Chronic Subdural Hematoma Rat Model
Xiaoyukang Jiaonang (XYK) is a Chinese patent medicine approved by the National Medical Product Administration which is used to treat intracranial hematoma in China. In this study, we observed the molecular mechanism of XYK in hypoxia-inducible factor 1α (HIF-1α), inflammation and angiogenesis of ch...
Autores principales: | Liu, Jialin, Dong, Xiaoke, Li, Zhonghao, Wang, Gesheng, Zhou, Yujia, Liu, Chongchong, Wang, Kaiyue, Li, Lili, Liu, Jinmin |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Hindawi
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7165346/ https://www.ncbi.nlm.nih.gov/pubmed/32328124 http://dx.doi.org/10.1155/2020/2305017 |
Ejemplares similares
-
Stem cell-based therapies for ischemic stroke: a systematic review and meta-analysis of clinical trials
por: Li, Zhonghao, et al.
Publicado: (2020) -
Chinese herbal injections combined with rt-PA intravenous thrombolysis for acute ischemic stroke: A systematic review and meta-analysis protocol
por: Wu, Jing, et al.
Publicado: (2021) -
Traumatic Spinal Subdural Hematoma with Intracranial Subdural Hematoma
por: Kim, Hyun Gon, et al.
Publicado: (2014) -
Spinal Subdural Hematoma Associated with Intracranial Subdural Hematoma
por: Kim, Myoung Soo, et al.
Publicado: (2015) -
From antiangiogenesis to hypoxia: current research and future directions
por: Rice, Christopher, et al.
Publicado: (2010)